Recombinant human thrombopoietin in treatment of chemotherapy-induced thrombocytopenia in patients with acute leukemia

冷芸, 陈文明, 李利红. 去甲氧基柔红霉素与柔红霉素方案对初治白血病的疗效 [J]. 临床血液学杂志, 2008.488.

张之南. 血液病诊断与疗效标准 [M]. 北京:科学出版社, 2003.168.

Camtor S B, Elting L S, Hudson DY Jr. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11)for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy [J]. Cancer, 2003, (12):3099.

Cairo M S, Davenport V, Bessmertny O. Phase Ⅰ/Ⅱ dose escalation study of recombinant human interleulin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumouts or lymphoma:a clinica, l haematological and biological study [J]. British Journal of Haematology, 2005(1):49.

Connie L, Millera E, DeLormeb E. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist [J]. Experimental Hematology, 2005(1):85.

Tijssen M R, diSummaF, Van denOudenrijn S. Functionalanalysis of single amino-acid mutations in the thrombopoietin-receptorMpl underlying congenital arnegakaryocytic thrombocytopenia [J]. British Journal of Haematology, 2008.808.

Bhatia M, Davenport V, Cairo M S. The role of interleukin11 toprevent chemotherapy-induced thrombocytopenia in patients withsolid tumors, lymphoma, acute myeloid leukemia and hone marrow failure syndromes [J]. Leukemia and Lymphoma, 2007.9.

Kuter D J, Begley C G. Recombinant human thrombopoietin:basic biology and evaluation of clinical studies [J]. Blood, 2002, (10):3457.

赵永强, 姜杰玲, 焦力. 重组人血小板生成素临床耐受性试验 [J]. 中华医学杂志, 2001, (24):1508.doi: 10.3760/j:issn:0376-2491.2001.24.012.

Vadhan-Raj S, Verschraegen C F, Bueso Ramos C. Recombinant human thrombopoietin attenuates carboplatininduced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer [J]. Annals of Internal Medicine, 2002(5):364.

Vadhan-Raj S. Recombinant human thrombopoietin in myelosup pressive chemotherapy [J]. Oncology, 2001, (7/Suppl 8):35.